Table A1.
Writing Group Disclosure Table
| Writing group | Consultant/ advisory board | Speakers’ bureau/ honoraria | Research grant | Fellowship support | Board Mbs/stock options/partner | Others |
|---|---|---|---|---|---|---|
| Joseph G. Akar, MD, PhD, HRS | None | None | None | None | None | None |
| Janice L. Baker, MSN, CCRN, CEPS, FHRS | None | None | None | None | None | None |
| Salwa Beheiry, MSN, RN, BSN, CCRN, HRS | None | None | None | None | None | None |
| Douglas Beinborn, RN, MA, HRS | 1: Mediasphere Medical, Abiomed | None | None | None | None | None |
| John F. Beshai, MD, FHRS | 4: Lifewatch | None | None | None | 1: American College of Cardiology | None |
| Neil Brysiewicz, BSBME, MS, HRS | None | None | None | None | None | None |
| Christine Chiu-Man, MS, CEPS, CCDS, FHRS | None | None | None | None | None | 1: St. Jude Medical, Medtronic |
| Kathryn K. Collins, MD, FHRS | None | None | None | None | None | None |
| Matthew Dare, CEPS, HRS | 1: Stereotaxis, Medtronic, Biosense Webster | None | None | None | None | None |
| Kenneth Fetterly, PhD | None | None | None | None | None | None |
| John D. Fischer, MD, FHRS | 2: Medtronic | 1: Sanofi-Aventis | 1: Medtronic, Boston Scientific, St. Jude Medical, Biotronik, Sanofi-Aventis | 2: Biotronik; 3: Medtronic, Boston Scientific, St. Jude Medical | None | None |
| David E. Haines MD, FHRS | None | None | None | None | None | Equity interest; 0: nContact Surgical |
| Richard Hongo, MD, FHRS | 1: Medtronic, St. Jude Medical, Boston Scientific | 1: Boston Scientific, Medtronic, St. Jude Medical, Sanofi-Aventis | None | None | None | None |
| Samuel Irefin, MD | None | None | None | None | None | None |
| John Lopez, BS, BSN, RN, HRS | None | None | None | None | None | 1: St. Jude Medical, Boston Scientific, Medtronic, Biotronik, Biosense Webster |
| John M. Miller, MD, FHRS | 1: Biotronik, Boston Scientific, Biosense Webster, Medtronic, Stereotaxis, St. Jude Medical, Topera | None | None | 3: Medtronic; 4: Biosense Webster, Biotronik | None | None |
| James C. Perry, MD, FHRS | 1: Medtronic, U.S. Department of Justice | None | 2: Medtronic | None | None | None |
| David J. Slotwiner, MD, HRS | None | None | None | None | None | None |
| Gery F. Tomassoni, MD, FHRS, FACC | 1: St. Jude Medical, Biosense Webster, Boston Scientific, Stereotaxis, Medtronic | 1: Biosense Webster, Boston Scientific, Medtronic, Stereotaxis, Pfizer, Sanofi-Aventis; 2: St. Jude Medical | None | None | None | 1: Stereotaxis |
| Esther Weiss, RN | None | None | None | None | None | None |
0 = $0; 1 = <$10,000; 2 = >$10,000 to <$25,000; 3 = >$25,000 to <$50,000; 4 = >$50,000 to <$100,000; 5 = >$100,000.